{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:58:45Z","timestamp":1791939525516,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jiac.2018.04.016","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T06:39:10Z","timestamp":1527143950000},"page":"944-947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum \u03b2-lactamase-producing and non-producing Escherichia coli"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-4791","authenticated-orcid":false,"given":"Yuto","family":"Haruki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-1891","authenticated-orcid":false,"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.04.016_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2018.04.016_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A\u00a0multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.04.016_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jiac.2016.02.004","article-title":"Prevalence and risk factors of infections caused by extended-spectrum \u03b2-lactamase (ESBL)-producing Enterobacteriaceae","volume":"22","author":"Nakai","year":"2016","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2018.04.016_bib4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Antibacterial Resistance Leadership Group. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jiac.2018.04.016_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1469-0691.2007.01864.x","article-title":"Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam","volume":"14","author":"Peterson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2018.04.016_bib6","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.00701-15","article-title":"Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-\u03b2-lactamase-producing Escherichia coli bacteremia","volume":"59","author":"Matsumura","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.04.016_bib7","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/CCM.0b013e31819ced02","article-title":"Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit","volume":"37","author":"Shorr","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2018.04.016_bib8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2169\/internalmedicine.56.7702","article-title":"Clinical characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli at a tertiary hospital","volume":"56","author":"Namikawa","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2018.04.016_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1469-0691.2007.01884.x","article-title":"Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"14","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2018.04.016_bib10","series-title":"Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.jiac.2018.04.016_bib11","series-title":"Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"10.1016\/j.jiac.2018.04.016_bib12","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.jiac.2018.04.016_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2018.04.016_bib14","first-page":"906","article-title":"REIPI\/ESGBIS\/INCREMENT Group. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae","volume":"72","author":"Palacios-Baena","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.04.016_bib15","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18301272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18301272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:30Z","timestamp":1761159510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18301272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1341321X18301272"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.04.016","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum \u03b2-lactamase-producing and non-producing Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}